https://doi.org/10.4081/itjm.2025.2251
P58 | An unusual pancytopenia
L. Delle Donne, L. Lenzi, M. Bertoldi, S. Rizzardo, S. Cozzio| Medicina Interna, Rovereto, Italy
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 26 August 2025
Introduction: SARS CoV2 infection can affect various organs and systems. The laboratory aspects include lymphopenia and thrombocytopenia.
Case presentation: 74 year old male patient, admitted to the emergency room for asthenia, chest discomfort. Suffering from chronic inflammatory demyelinating polyneuropathy, treated with prednisone 25 mg and azathioprine 50 mg. Apiretic, objectivity normal, except for weakness in the lower limbs. No respiratory failure, chest x-ray negative for pneumonia, blood tests leukocytes (WBC) 2.4x109/L, hemoglobin (Hb) 8.9 g/dL, C-reactive protein 148 mg/L (vn <6), platelets normal. Nasopharyngeal swab FREND COVID-19 Ag positive. Hospitalized, azathioprine therapy suspended, onset of fever. Rapidly worsening pancytopenia, nadir after the sixth day with total WBC 0.6 x109/L, platelets 16,000, Hb 7 g/dL. Excluding vitamin deficiencies. Patient treated with piperacillin-tazobactam, remdesivir, granulocyte growth factor (G-CSF) and blood transfusions. The patient underwent bone marrow aspirate from the iliac crest with a modest increase in the blast rate (possible effect of G-CSF) with slow maturation of the granulocyte series and no significant signs of dysplasia affecting the elements of the hematopoietic matrix. Nine days after admission, the blood count improved, with very rapid restoration of normal values and complete clinical recovery.
Conclusions: Severe pancytopenia represents a rare complication of SARS-CoV2. In pancytopenic patients it is useful to exclude SARSCoV2 infection to avoid subjecting the patient to invasive diagnostics.
Downloads
How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.